Limited Treatment Options in Primary Hyperoxaluria with Renal Failure
- PMID: 33173783
- PMCID: PMC7588674
- DOI: 10.1159/000510143
Limited Treatment Options in Primary Hyperoxaluria with Renal Failure
Abstract
Primary hyperoxaluria (PH) is a rare autosomal recessive metabolic disorder where serum oxalate levels rise due to overproduction. The kidney tubule is a main target for oxalate deposition, resulting in damage to the organ. Kidney failure is rare in these patients. We present a 67-year-old female with hemodialysis-dependent end-stage renal disease likely due to PH type 2 or 3. With extremely high levels of serum oxalate (60.4 μmol/L), this patient had minimal treatment options for her rare disease. This report details a unique presentation of a rare disease where kidney biopsy was instrumental.
Keywords: Chronic hemodialysis; Chronic renal failure; Genetic diseases; Primary hyperoxaluria; Renal biopsy.
Copyright © 2020 by S. Karger AG, Basel.
Conflict of interest statement
The authors have no conflicts of interest to declare.
Figures
References
-
- Bouzidi H, Majdoub A, Daudon M, Najjar MF. [Primary hyperoxaluria: A review] Nephrol Ther. 2016 Nov;12((6)):431–6. - PubMed
-
- Genetics Home Reference Primary hyperoxaluria. https://ghr.nlm.nih.gov/condition/primary-hyperoxaluria(accessed Mar. 11, 2020)
-
- Kasidas GP, Rose GA. Measurement of plasma oxalate in healthy subjects and in patients with chronic renal failure using immobilised oxalate oxidase. Clin Chim Acta. 1986 Jan;154((1)):49–58. - PubMed
-
- Giafi CF, Rumsby G. Kinetic analysis and tissue distribution of human D-glycerate dehydrogenase/glyoxylate reductase and its relevance to the diagnosis of primary hyperoxaluria type 2. Ann Clin Biochem. 1998 Jan;35((Pt 1)):104–9. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
